Canada reports first cases of U.K. coronavirus variant. Here’s what you need to know - Global News | Canada News Media
Connect with us

News

Canada reports first cases of U.K. coronavirus variant. Here’s what you need to know – Global News

Published

 on


The discovery of a new, possibly more contagious variant of COVID-19 in Canada calls for more stringent lockdowns, curbs to international travel and a need to vaccinate people faster, experts say.

On Saturday, the country’s largest province of Ontario reported the first two cases of the coronavirus strain that was first identified in the United Kingdom and has since spread to Australia, Japan and several European countries.

Read more:
Ontario confirms Canada’s 1st known cases of U.K. coronavirus variant

Provincial officials said the cases involved a couple from Durham Region with no known travel history, but had been in contact with a recent traveller from the U.K. A third case, an individual who had recently travelled from the U.K., was found in Ottawa on Sunday, a provincial health official confirmed to Global News. All three are now in self-isolation.

Story continues below advertisement

“Not heeding the advice of some experts to seriously curtail international travel is now demonstrably a mistake,” Colin Furness, an infection control epidemiologist and assistant professor at the University of Toronto, told Global News.

“Nationally, we would do well to speed up vaccination and curtail international travel,” he said.






3:42
What we know about the new strain of coronavirus


What we know about the new strain of coronavirus

Canada suspended flights from the U.K. on Dec. 20 for 72 hours due to concerns over the new variant and has since extended the suspension until Jan. 6, 2021.

Travellers are now asked “additional health screening questions” to see if they had visited a country that has reported the variant, according to Health Canada.

All travellers arriving in Canada are required to quarantine for 14 days.

What is the new variant?

Mutations, which are small changes in the genetic material of the virus, are common during outbreaks.

Story continues below advertisement

The U.K. variant was first announced by the British government on Dec. 14.

Read more:
Masks, handwashing and distancing remain key amid new U.K. coronavirus variant, doctors say

The strain, referred to by some experts as the B.1.1.7 lineage, is not the first new variant of COVID-19, but it has rapidly become the dominant strain in cases of COVID-19 in many parts of U.K. To date, there is no evidence that it causes more severe illness.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

But the variant is said to be up to 70 per cent more transmissible than the previously dominant strain in the U.K and its cases has been found in several European countries, including France, Spain, Sweden, Switzerland and the Netherlands.

In recent weeks, at least two other variants have also been identified in South Africa and Nigeria.






3:12
Travellers arriving from UK encouraged to immediately be tested for COVID-19


Travellers arriving from UK encouraged to immediately be tested for COVID-19

Dr. Zain Chagla, medical director of infection control with St. Joseph’s Healthcare Hamilton, said the new variants are similar to the current strain by “over 99 per cent” and there may also be other variants emerging in different countries that have not been detected due a lack of aggressive sequencing.

Story continues below advertisement

In a statement on Saturday, Health Canada said Canadian and global medical communities are actively evaluating the mutations.

“As the monitoring continues, it is expected that other cases of this variant and other variants of concern may be found in Canada,” the agency said.

Dr. Gerald Evans, chair of infectious diseases division at Queen’s University in Kingston, Ont., said the SARS-CoV-2 virus is mutating fairly slowly and the frequency of new strains arising is “not excessive” at the moment

“It’s just that the sheer number of infected humans is so large that we are seeing mutations developing simply from the extraordinary frequency of viral replication globally,” he told Global News.






0:52
Coronavirus: Trudeau extends travel ban on U.K. for two weeks amid discovery of new COVID-19 variant


Coronavirus: Trudeau extends travel ban on U.K. for two weeks amid discovery of new COVID-19 variant

Ontario went into a province-wide lockdown earlier on Saturday, coinciding with Boxing Day, in an effort to curb the spread of the rising number of cases and hospitalizations.

Story continues below advertisement

Dr. Barbara Yaffe, the province’s associate chief medical officer of health, said the new variant “further reinforces the need for Ontarians to stay home as much as possible.”

In light of recent developments, experts are urging people across the country not to panic and to continue adhering to public health measures.

“We’re in fairly strict restrictions and the same ones apply to preventing the B.1.1.7 variant — masking when indoors, testing with any symptoms, distancing, and staying home as much as possible,” Chagla said.

What does this mean for the vaccines?

Canada has so far approved two coronavirus vaccines by Pfizer-BioNTech and Moderna.

The country began its nationwide vaccine rollout earlier this month, with up to 249,000 doses of Pfizer’s vaccine and 168,000 from Moderna expected by the end of the year.

Read more:
‘No need to panic’: COVID-19 mutations unlikely to impact vaccine, experts say

Experts and health officials say there is no evidence to suggest that the vaccines will not be effective against the new variants.

“So far, early preliminary studies, not yet published, show that immunity induced by the current vaccine produces neutralizing antibodies that are effective against variants with the N501Y mutation,” Evans said.

Story continues below advertisement

“We will need further studies to corroborate these findings along with other mutations that have been documented.”

Chagla agreed. “Most indications are that the vaccines are spared,” he said.

“Both Pfizer and Moderna will confirm this in the coming weeks.”






1:16
Coronavirus: Heath Canada official says Moderna vaccine believed to be effective against new U.K. variant


Coronavirus: Heath Canada official says Moderna vaccine believed to be effective against new U.K. variant

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version